Up Next
0
ISM & Pharma's Merger Monday
The FMHR traders weigh in on how to play today's weak manufacturing numbers; Goldman's call on an eight-percent drop in the S&P. Also, China's soft economic data. And Mark Schoenebaum, ISI Group analyst, discusses the merger between Bristol-Myers and Amylin Pharma and whether the pharma sector is on the verge of consolidation.
Share
ISM & Pharma's Merger Monday
The FMHR traders weigh in on how to play today's weak manufacturing numbers; Goldman's call on an eight-percent drop in the S&P. Also, China's soft economic data. And Mark Schoenebaum, ISI Group analyst, discusses the merger between Bristol-Myers and Amylin Pharma and whether the pharma sector is on the verge of consolidation.
Date: 7/2/12
Views: 20
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56